Revision 1

#18764Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IP

REACTIVITY:

H M R Mk

SENSITIVITY:

Endogenous

MW (kDa):

62

Source/Isotype:

Rabbit IgG

UniProt ID:

#Q9Y232

Entrez-Gene Id:

9425

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:100

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

CDYL (E7S8T) Rabbit mAb recognizes endogenous levels of total CDYL protein.

Species Reactivity:

Human, Mouse, Rat, Monkey

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly255 of human CDYL protein.

Background

Chromodomain Y-like (CDYL) is a transcriptional corepressor and chromatin reader that recognizes the histone marks H3K9me3, H3K27me2, and H3K27me3, which are typically associated with repressive chromatin states and inhibition of gene expression. CDYL functions as a molecular bridge between the histone H3K9 methyltransferase G9a/EHMT2 and the transcription repressor REST, targeting G9a to the loci of REST target genes (1,2). CDYL has also been shown to directly interact with EZH2, the catalytic subunit of the Polycomb Repressive Complex 2 (PRC2), where it recruits EZH2 to H3K27me3 sites and propagates this repressive modification along chromatin (3). CDYL binds to methylated histone lysine residues through its N-terminal chromodomain, while its C-terminal enoyl-coenzyme A (CoA) hydratase-isomerase catalytic domain may be involved in histone lysine crotonylation (4). Knockout of CDYL is largely embryonic lethal in mice, with few mice surviving and dying shortly after birth (5). Additional studies in mice show that knockdown of CDYL appears to disrupt normal neuronal migration and brain development, possibly due to the loss of RhoA transcriptional repression (6).

  1. Mulligan, P. et al. (2008) Mol Cell 32, 718-26.
  2. Franz, H. et al. (2009) J Biol Chem 284, 35049-59.
  3. Zhang, Y. et al. (2011) J Biol Chem 286, 42414-42425.
  4. Liu, S. et al. (2017) Mol Cell 67, 853-866.e5.
  5. Wan, L. et al. (2013) Neuroreport 24, 114-9.
  6. Qin, R. et al. (2017) Cell Rep 18, 380-390.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IP: Immunoprecipitation

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.